EUVIMEDEUVIMED entdecken
Crossref

Interatrial Block Association With Adverse Cardiovascular Outcomes in Patients Without a History of Atrial Fibrillation

Joshua Lampert, David Power, Shreyas Havaldar, Usha Govindarajulu, Iwanari Kawamura, Abhishek Maan, Marc A Miller, Kartikeya Menon, Jacob Koruth, William Whang, Emilia Bagiella, Antoni Bayes-Genis und 10 weitere

JACC: Clinical Electrophysiology · 2023-08 · 9 (8) · 1804-1815

DOI: 10.1016/j.jacep.2023.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2023-08. Verfasst von Joshua Lampert und 21 weiteren Autor:innen. Beteiligte Einrichtung: Helmsley Electrophysiology Center, Mount Sinai Hospital, New York, New York, USA. Electronic address: https://twitter.com/joshuamlampertmd. Hauptthemen laut MEDLINE: Atrial Fibrillation, Stroke, Atrial Flutter, Thromboembolism. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Interatrial block (IAB) is associated with thromboembolism and atrial arrhythmias. However, prior studies included small patient cohorts so it remains unclear whether IAB predicts adverse outcomes particularly in context of atrial fibrillation (AF)/atrial flutter (AFL). OBJECTIVES: This study sought to determine whether IAB portends increased stroke risk in a large cohort in the presence or absence of AFAF/AFL. METHODS: We performed a 5-center retrospective analysis of 4,837,989 electrocardiograms (ECGs) from 1,228,291 patients. IAB was defined as P-wave duration ≥120 ms in leads II, III, or aVF. Measurements were extracted as .XML files. After excluding patients with prior AF/AFL, 1,825,958 ECGs from 458,994 patients remained. Outcomes were analyzed using restricted mean survival time analysis and restricted mean time lost. RESULTS: There were 86,317 patients with IAB and 355,032 patients without IAB. IAB prevalence in the cohort was 19.6% and was most common in Black (26.1%), White (20.9%), and Hispanic (18.5%) patients and least prevalent in Native Americans (9.2%). IAB was independently associated with increased stroke probability (restricted mean time lost ratio coefficient [RMTLRC]: 1.43; 95% CI: 1.35-1.51; tau = 1,895), mortality (RMTLRC: 1.14; 95% CI: 1.07-1.21; tau = 1,924), heart failure (RMTLRC: 1.94; 95% CI: 1.83-2.04; tau = 1,921), systemic thromboembolism (RMTLRC: 1.62; 95% CI: 1.53-1.71; tau = 1,897), and incident AF/AFL (RMTLRC: 1.16; 95% CI: 1.10-1.22; tau = 1,888). IAB was not associated with stroke in patients with pre-existing AF/AFL. CONCLUSIONS: IAB is independently associated with stroke in patients with no history of AF/AFL even after adjustment for incident AF/AFL and CHA2DS2-VASc score. Patients are at increased risk of stroke even when AF/AFL is not identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationStrokeAtrial FlutterThromboembolismHumansInteratrial BlockRetrospective StudiesElectrocardiography

Stichwörter der Autor:innen

atrial fibrillationelectrocardiogramfibrosisheart failureinteratrial blockstroke

Autor:innen und Institutionen

  • Helmsley Electrophysiology Center, Mount Sinai Hospital, New York, New York, USA. Electronic address: https://twitter.com/joshuamlampertmd.
  • Mount Sinai Heart, Mount Sinai Hospital, New York, New York, USA.
  • Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Center for Biostatistics, Department of Population Health, Mount Sinai Hospital, New York, New York, USA.
  • Helmsley Electrophysiology Center, Mount Sinai Hospital, New York, New York, USA.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Zitieren

APA

Lampert, J., Power, D., Havaldar, S., Govindarajulu, U., Kawamura, I., Maan, A., Miller, M. A., Menon, K., Koruth, J., Whang, W., Bagiella, E., Bayes-Genis, A., Musikantow, D., Turagam, M., Bayes de Luna, A., Halperin, J., Dukkipati, S. R., Vaid, A., Nadkarni, G., …, & Reddy, V. Y. (2023). Interatrial Block Association With Adverse Cardiovascular Outcomes in Patients Without a History of Atrial Fibrillation. JACC: Clinical Electrophysiology, 9(8), 1804-1815. https://doi.org/10.1016/j.jacep.2023.04.006

Vancouver

Lampert J, Power D, Havaldar S, Govindarajulu U, Kawamura I, Maan A, et al. Interatrial Block Association With Adverse Cardiovascular Outcomes in Patients Without a History of Atrial Fibrillation. JACC: Clinical Electrophysiology. 2023;9(8):1804-1815. doi:10.1016/j.jacep.2023.04.006

BibTeX
@article{Lampert2023,
  author = {Lampert, Joshua and Power, David and Havaldar, Shreyas and Govindarajulu, Usha and Kawamura, Iwanari and Maan, Abhishek and Miller, Marc A and Menon, Kartikeya and Koruth, Jacob and Whang, William and Bagiella, Emilia and Bayes-Genis, Antoni and Musikantow, Daniel and Turagam, Mohit and Bayes de Luna, Antoni and Halperin, Jonathan and Dukkipati, Srinivas R and Vaid, Akhil and Nadkarni, Girish and Glicksberg, Benjamin and Fuster, Valentin and Reddy, Vivek Y},
  title = {Interatrial Block Association With Adverse Cardiovascular Outcomes in Patients Without a History of Atrial Fibrillation},
  journal = {JACC: Clinical Electrophysiology},
  year = {2023},
  volume = {9},
  number = {8},
  pages = {1804--1815},
  doi = {10.1016/j.jacep.2023.04.006}
}
Kostenlos starten →